JPWO2021092090A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021092090A5
JPWO2021092090A5 JP2022525169A JP2022525169A JPWO2021092090A5 JP WO2021092090 A5 JPWO2021092090 A5 JP WO2021092090A5 JP 2022525169 A JP2022525169 A JP 2022525169A JP 2022525169 A JP2022525169 A JP 2022525169A JP WO2021092090 A5 JPWO2021092090 A5 JP WO2021092090A5
Authority
JP
Japan
Prior art keywords
subject
palmar
compound
skin
plantar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022525169A
Other languages
Japanese (ja)
Other versions
JP2022554264A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/058978 external-priority patent/WO2021092090A1/en
Publication of JP2022554264A publication Critical patent/JP2022554264A/en
Publication of JPWO2021092090A5 publication Critical patent/JPWO2021092090A5/ja
Pending legal-status Critical Current

Links

Claims (1)

それを必要とする対象への化合物の手掌又は足底投与のための方法であって、
a.前記対象の前記手掌又は足底の皮膚に抗コリン性化合物を投与するステップ;及び
b.前記化合物が前記対象の前記手掌又は足底の皮膚に対する抗コリン性効果を有するのに十分な時間、前記対象の前記手掌又は足底の皮膚を遮蔽するステップ
を含む、前記方法。
A method for palmar or plantar administration of a compound to a subject in need thereof, the method comprising:
a. administering an anticholinergic compound to the skin of the palms or soles of the subject; and b. The method comprises masking the palmar or plantar skin of the subject for a sufficient period of time for the compound to have an anticholinergic effect on the palmar or plantar skin of the subject.
JP2022525169A 2019-11-05 2020-11-04 Methods for Palmar or Plantar Administration of Pharmaceutical Compositions Pending JP2022554264A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962931139P 2019-11-05 2019-11-05
US62/931,139 2019-11-05
PCT/US2020/058978 WO2021092090A1 (en) 2019-11-05 2020-11-04 Methods for palmar or plantar administration of pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2022554264A JP2022554264A (en) 2022-12-28
JPWO2021092090A5 true JPWO2021092090A5 (en) 2023-11-13

Family

ID=73599007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022525169A Pending JP2022554264A (en) 2019-11-05 2020-11-04 Methods for Palmar or Plantar Administration of Pharmaceutical Compositions

Country Status (3)

Country Link
US (1) US20220401412A1 (en)
JP (1) JP2022554264A (en)
WO (1) WO2021092090A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2135444A1 (en) * 1971-05-05 1972-12-22 Amphoux Maurice Antiperspiration under - glove - for use inside air-tight protective gloves
CA2461696A1 (en) * 2001-09-26 2003-04-03 Alison B. Lukacsko Compositions and methods for inhibiting eccrine perspiration in humans
CN101340884A (en) * 2005-10-19 2009-01-07 曼尼·马纳舍·辛格尔 Methods for the treatment of hyperhidrosis
US20100082088A1 (en) * 2008-08-27 2010-04-01 Ali Fassih Treatment of sweating and hyperhydrosis
US20150037269A1 (en) * 2013-07-30 2015-02-05 Glaxosmithkline Intellectual Property Development Limited Topical compositions for treatment of excessive sweating and methods of use thereof
GB2532811B (en) * 2014-11-18 2017-07-26 Atg Ceylon (Private) Ltd Anti-Perspirant Glove

Similar Documents

Publication Publication Date Title
JP2006501240A5 (en)
RU2018110647A (en) Aryl, heteroaryl and heterocyclic compounds for the treatment of diseases
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
CO2021008988A2 (en) Combination of dextromethorphan and bupropion for the treatment of depression
JP2008505857A5 (en)
RS52942B (en) Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione
CO2018006358A2 (en) Treatment of fabry disease in patients not treated and previously treated with ert
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
RU2008119454A (en) MEDICINE FOR PROTECTION OF MOTOR NEURON IN PATIENTS WITH LATERAL AMYOTROPHIC SCLEROSIS
RU2018125622A (en) METHOD OF APPLICATION OF CARRYMICIN AGAINST RESISTANCE OF INFECTION PROVIDED BY MYCOBACTERIA TUBERCULOSIS
PH12020551911A1 (en) Use of riluzole oral disintigrating tablets for treating diseases
JP2020529995A5 (en)
MX2020001342A (en) Use of gaboxadol in the treatment of diabetes and related conditions.
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
EA200800075A1 (en) DOSING CIRCUIT FOR WISE
JP2013536837A5 (en)
DE602004024221D1 (en) TREATMENT OF INFLAMMATORY ENDURANCE DISEASES WITH 2-METHYLENE-19-NOR-VITAMIN D COMPOUNDS
JP2005508963A5 (en)
JPWO2021092090A5 (en)
DK1732551T3 (en) Perhexilin for the treatment of chronic heart failure
JP2004521140A5 (en)
CR8584A (en) PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS
Mehta et al. Generalized lichen nitidus in childhood
ATE298240T1 (en) SEPARATE DOSE THERAPIES WITH VASCULAR DAMAGED ACTIVITY
JP2003212765A (en) Solution for stopping symptom of athlete's foot